CardioGenesis Laser Therapies for Angina and Heart Disease Patients 4 23 03 Q 1 03 Page 3
CARDIOGENESIS CORPORATION REPORTS 2003 FIRST QUARTER RESULTS
PAGE 3-3-3
For more information on the Company and its products, please visit the CardioGenesis
web site at
http://www.cardiogenesis.com
. For investor relations information, visit the
CardioGenesis pages in the "Client" section of the Allen & Caron Inc web site at
www.allencaron.com
.
Any forward-looking statements in this news release related to the Company's sales, profitability, the adoption of its
technology and products and FDA clearances are based on current expectations and beliefs and are subject to
numerous risks and uncertainties that could cause actual results to differ materially. Other factors that could cause
CardioGenesis' actual results to differ materially are discussed in the "Risk Factors" section of the Company's
Annual Report on Form 10-K for the year ended December 31, 2002, and the Company's other recent SEC filings.
The Company disclaims any obligation to update any forward-looking statements as a result of developments
occurring after the date of this press release.
TABLES FOLLOW
